Syndax Pharmaceuticals
SNDX
SNDX
210 hedge funds and large institutions have $1.71B invested in Syndax Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 86 increasing their positions, 58 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% more call options, than puts
Call options by funds: $16.2M | Put options by funds: $14.9M
4% less capital invested
Capital invested by funds: $1.79B → $1.71B (-$80M)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
Holders
210
Holding in Top 10
9
Calls
$16.2M
Puts
$14.9M
Top Buyers
| 1 | +$15.2M | |
| 2 | +$15.1M | |
| 3 | +$10.5M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$9.63M |
| 5 |
EP
Eversept Partners
New York
|
+$9.46M |
Top Sellers
| 1 | -$45.3M | |
| 2 | -$26.3M | |
| 3 | -$16.9M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$16.2M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$5.92M |